Literature DB >> 2718698

Regulation of uterine insulin-like growth factor I mRNA and insulin-like growth factor II mRNA by estrogen in the rat.

G Norstedt1, A Levinovitz, H Eriksson.   

Abstract

IGF-I and IGF-II are peptides with mitogenic properties. In this study mRNA for IGF-I and IGF-II was analysed in rat uterine tissue after different endocrine manipulations and the possibility of an estrogenic regulation of IGF expression was investigated. Both IGF-I and IGF-II mRNA were present in uterine tissue. The level of IGF-I mRNA, but not IGF-II mRNA, was reduced following ovariectomy. Administration of estradiol (2.5 micrograms/day for 4 days) to ovariectomized rats increased IGF-I mRNA 8-fold to levels seen in intact animals. In adult animals hepatic IGF-I mRNA did not appear to be increased by estrogen treatment. Low levels of IGF-II mRNA were detected in the uterus, but showed no dependence on estrogen. The inductive effect of estrogen on uterine IGF-I mRNA could not be substituted for by growth hormone administration (0.5 mg/100 g, ip for 6 h). The present results suggest IGF-I as a potential candidate for a mediator of estrogen-induced growth. Both estrogen and GH induce IGF-I mRNA and a tissue specificity for these hormones is indicated where GH regulates hepatic and estrogen uterine IGF-I mRNA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2718698     DOI: 10.1530/acta.0.1200466

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  8 in total

Review 1.  Growth hormone--a cogonadotropin? Its role in ovulation induction.

Authors:  Z Blumenfeld
Journal:  J In Vitro Fert Embryo Transf       Date:  1991-06

Review 2.  Medical treatment of uterine leiomyoma.

Authors:  Mohamed Sabry; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2012-02-28       Impact factor: 3.060

3.  Insulin-like growth factor 1 is required for G2 progression in the estradiol-induced mitotic cycle.

Authors:  O O Adesanya; J Zhou; C Samathanam; L Powell-Braxton; C A Bondy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

4.  Effect of two-4-hydroxyandrostenedione doses on serum insulin-like growth factor I levels in advanced breast cancer.

Authors:  L Ferrari; N Zilembo; E Bajetta; R Buzzoni; C Noberasco; A Martinetti; L Celio; E Galante; S Orefice; A M Cerrotta
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

5.  Innovative oral treatments of uterine leiomyoma.

Authors:  Mohamed Sabry; Ayman Al-Hendy
Journal:  Obstet Gynecol Int       Date:  2012-02-16

6.  DNA microarray data integration by ortholog gene analysis reveals potential molecular mechanisms of estrogen-dependent growth of human uterine fibroids.

Authors:  Tao Wei; Andrew G Geiser; Hui-Rong Qian; Chen Su; Leah M Helvering; Nalini H Kulkarini; Jianyong Shou; Mathias N'Cho; Henry U Bryant; Jude E Onyia
Journal:  BMC Womens Health       Date:  2007-04-02       Impact factor: 2.809

7.  Effects of SERM (selective estrogen receptor modulator) treatment on growth and proliferation in the rat uterus.

Authors:  Denis Stygar; Natalia Muravitskaya; Britt Eriksson; Håkan Eriksson; Lena Sahlin
Journal:  Reprod Biol Endocrinol       Date:  2003-05-07       Impact factor: 5.211

Review 8.  Uterine fibroids: current perspectives.

Authors:  Aamir T Khan; Manjeet Shehmar; Janesh K Gupta
Journal:  Int J Womens Health       Date:  2014-01-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.